DHA Group history

The facility was its second, Martek having purchased its first fermentation plant, located in Winchester, Kentucky, from Coors Brewing Co. in 1995.

In 1996, it had experienced a loss of $8.9 million.

In 1997, it had a net loss of $15.4 million with revenues of $4.4 million.

1998: Martek collaborates with SmithKline Beecham on research involving the use of Martek's patented Reconnaissance Probe technology.

When Abbott Laboratories signed a worldwide licensing agreement with Martek in April 2000, Martek gained access to 60 percent of the worldwide infant formula market.

Another breakthrough occurred for Martek in 2001 when researchers in its labs and at the Carnegie Institute of Washington figured out a way to make one species of single-celled algae grow without light.

In 2002, Martek raised another $22 million through the private sale of common stock, some of which it used to acquire OmegaTech Inc. of Boulder, Colorado, an algal DHA producer.

Liat Ben-Moshe and Sandy Magaña, “An Introduction to Race, Gender, and Disability: Intersectionality, Disability Studies, and Families of Color,” Women, Gender, and Families of Color 2.2. (Fall 2014): 105-114.

Angel L. Miles, Akemi Nishida, Anjali J. Frober-Pratt, “An Open Letter to White Disability Studie and Ableist Institutions of Higher Education,” Disability Studies Quarterly 37.3 (August 2017).